Inventors:
Berislav V. Zlokovic - Rochester NY, US
Dong Liu - Rochester NY, US
Tong Cheng - Webster NY, US
Huang Guo - Pittsford NY, US
International Classification:
A61K 38/48, C40B 30/06, A61P 9/00
Abstract:
Activated protein C (APC), a prodrug, and/or a variant of APC may be used to inhibit undesirable effects of plasminogen activator: e.g., apoptosis or cell death of neurons and endothelial cells, brain hemorrhage or intracerebral bleeding, and/or tissue damage in a subject's brain. Inhibition appears to act through the extrinsic pathway of death receptor signal transduction. This represents an improvement in treatment using plasminogen activator (e.g., fibrinolysis). By reducing undesirable effects, the window for fibrinolytic therapy by plasminogen activator may be widened.